Korsuva

FDA Approvals Roundup: Korsuva, Jardiance, Xarelto
RAPS.org
Fri, 08/27/21 - 10:36 am
Cara Therapeutics
Korsuva
Boehringer Ingelheim
Jardiance
Bristol Myers Squibb
Opdivo
Cara’s Korsuva is first drug cleared for itching in dialysis patients
Pharmaforum
Tue, 08/24/21 - 10:52 pm
Cara Therapeutics
Korsuva
dialysis
chronic kidney disease
FDA Action Alert: Cara/Vifor, Kadmon, BMS, Merck/Eisai
BioSpace
Mon, 08/23/21 - 11:10 am
FDA
Cara Therapeutics
Vifor Pharma
Korsuva
Kadmon
belumosudil
Bristol Myers Squibb
Opdivo
Merck
Eisai
Keytruda
Cara's stock tanks as atopic dermatitis phase 2 misses endpoint
Fierce Biotech
Fri, 04/30/21 - 10:45 am
Cara Therapeutics
atopic dermatitis
eczema
clinical trials
Korsuva
Cara and Vifor's Korsuva Hits the Mark for Treating Severe Itching in Kidney Patients
BioSpace
Tue, 04/21/20 - 11:45 pm
Cara Therapeutics
Vifor Fresenius Medical Care Renal Pharma
Korsuva
kidney disease
Where Will Cara Therapeutics Be in 5 Years?
Motley Fool
Sat, 06/29/19 - 02:34 pm
Cara Therapeutics
Korsuva
Little Cara steers through their first positive PhIII with a ‘breakthrough’ drug and a path to the FDA
Endpoints
Wed, 05/29/19 - 10:48 pm
Cara Therapeutics
Korsuva
CR845
clinical trials
hemodialysis
Here's Why Cara Therapeutics Jumped 56.5% in the First Half of 2018
Motley Fool
Sun, 07/15/18 - 07:25 pm
Cara Therapeutics
CR845
Korsuva
Why Cara Therapeutics Shares Jumped 10% Friday
Motley Fool
Sat, 05/26/18 - 09:31 am
Cara Therapeutics
Korsuva
Vifor Fresenius Medical Care Renal Pharma
Forget Cara Therapeutics' Earnings -- Here's the Real News
Motley Fool
Thu, 05/17/18 - 09:51 pm
earnings
Cara Therapeutics
Korsuva